Dystrophic changes of nigrostriatal axons harboring a Synj1 Parkinson mutation suggest catastrophic failure of endocytic mechanisms
Output Details
Description
[Background] Synaptojanin 1 (Synj1) is a brain-enriched phosphoinositide phosphatase implicated in the endocytic recycling of synaptic vesicles at synapses. Mutations in SYNJ1 (alias PARK20) cause recessive familial early-onset Parkinsonism. We had previously found that mice harboring a patient mutation in Synj1 (R258Q in humans) have neurological manifestations similar to those of human patients and dystrophic changes of a subset of nigrostriatal domain axons. Further characterizing these changes was a goal of our ASAP project. [Gap] Mice with a PD patient mutation in SYNJ1 have neurological manifestations similar to those of human patients. They also have dystrophic changes in a subset of nigrostriatal neurons, but the precise nature of these changes had remained unclear. [Methods and key results] We have used correlative light-electron microscopy (FIB-SEM) to elucidate the distribution and 3D ultrastructure of abnormal axons of the mutant mice and recorded DA secretion in ex vivo striatal slices. We found that dystrophic changes only occur in a subpopulation of axons projecting to the dorsolateral striatum, which roughly overlap with an axonal population recently reported to be most vulnerable in Parkinson’s disease. Moreover, we show that dystrophic axons are characterized by massive onion-like dopamine transporter (DAT)-enriched plasma membrane infoldings, suggesting a catastrophic defect in plasma membrane endocytosis. [impact] Our findings provide mechanistic insight into pathogenic mechanisms underlying PD manifestations due to SYNJ1 mutations and call for an understanding of why a specific subpopulation of dopaminergic axons is so sensitive to the partial disruption of Synj1 function.
Identifier (DOI)
10.64898/2026.06.24.733515